Novogen Ltd Ads: (NASD: NVGN)
$3.93
-0.02 (-0.51%)
Volume 3,020
May 24 10:39 AM ET
Zacks Rank: NA 
| |
Overview Quote
Stock Activity
| Day Low - High | 3.92 - 4.03 |
| 52wk Low - High | 1.47 - 10.49 |
| Previous Close | 3.95 |
| Avg. Volume | 34,697 |
| Industry | MED-DRUGS |
| Market Cap | 16.40 M |
| Div - Yield | 0.00 - 0.00 |
| Beta | 1.65 |
| PE (Forward) | 0.00 |
| Current Year Est. | 0.00 |
| Quarterly Earnings ESP |
NA |
Premium research
Zacks Rank
|
|
Zacks Recommendation
|
No Zacks Recommendation |
Zacks Industry Rank
|
110 out of 265 |
Equity Research Report
|
PREMIUM |
( = Change in last 30 days)
Get all our stock ratings and recommendations with a Free Trial to Zacks Premium Start Free Trial
Key Earnings Data
| PE (Forward) | NA |
| PEG Ratio | NA |
| Current Year Est. | NA |
| Current Quarter Estimate | NA |
| Most Accurate Estimate | NA |
| Earnings ESP |
NA |
| Next Earnings Report Date | 05-24-2013 |
| EPS Last Year | NA |
| Expected Earnings Growth | NA |
Company Description
NOVOGEN LTD-ADR business is in the area of medicine know as degenerative diseases and disorders. Novogen is addressing this urgent area of medical need through the Novogen isoflavonoid technology platform - a platform that the Company believes offers the real prospect of not only treating, but also preventing, the onset of these common degenerative conditions. There are three divisions at Novagen: the pharmaceutical division, Marshall Edwards inc., and the consumer health division.
NYSE data is at least 20 minutes delayed.
NASDAQ data is at least 15 minutes delayed.
Turn Earnings Surprises into quick profits.
Earnings Estimates
| Current Qtr (ND) |
Next Qtr (ND) |
Current Year (ND) |
Next Year (ND) |
|
|---|---|---|---|---|
| Average Estimate | NA | NA | NA | NA |
| Number of Estimates | NA | NA | NA | NA |
| Low Estimate | NA | NA | NA | NA |
| High Estimate | NA | NA | NA | NA |
| Year Ago EPS | NA | NA | NA | NA |
| EPS Growth | NA | NA | NA | NA |
Industry Analysis
| Name | Symbol | Previous Close | Zacks Rank | Zacks Recommendation |
|---|---|---|---|---|
| JAZZ PHARMACEUT | JAZZ | 63.00 | |
|
| SALIX PHARM-LTD | SLXP | 59.69 | |
|
| SANTARUS INC | SNTS | 22.93 | |
|
| USANA HLTH SCI | USNA | 68.51 | |
|
| CATALYST PHARMA | CPRX | 0.84 | |
|
| CELL THERAPEUT | CTIC | 1.22 | |
|
| CUBIST PHARM | CBST | 56.03 | |
|
| ELAN CP PLC ADR | ELN | 12.36 | |
|
| INFINITY PHARMA | INFI | 24.36 | |
|
| LANNETT INC | LCI | 12.65 | |
|
Sector:Medical>> Industry:MED-DRUGS
COMPARE TICKER vs. Its Peers
Financials
| EPS TTM | NA |
| Sales | 2 |
| Net Income | NA |
| Price/Earnings | NA |
| Price/Book | 5.43 |
| Price/Cash Flow | NA |
| Price/Sales | NA |
News
NVGN, AVEO, QQEW, Removed From Naked Short Lists Today - M2
May 20, 2013
5 Stocks Poised to Break Out - TheStreet.com
May 10, 2013
NVGN, ABIO, RVXCF, QQEW, Added To Naked Short Lists Today - M2
May 9, 2013
Market Maker Surveillance Report. MVIS, BOSC, SABA, NVGN, FFIV, CHLN, Losing Stocks With Lowest Price Friction For Thursday, April 4th 2013 - M2
Apr 5, 2013
Morning Market Losers - Benzinga
Apr 4, 2013
Morning Market Movers - Benzinga
Apr 3, 2013
Market Maker Surveillance Report. STXS, NVGN, FUQI, IWSY, LEDS, HZNP, Winning Stocks With Lowest Price Friction For Monday, March 25th 2013 - M2
Mar 26, 2013
NVGN, ZIOP, TWER, Removed From Naked Short Lists Today - M2
Mar 20, 2013
Broker Recommendations
| Current ABR | NA |
| ABR (Last Week) | NA |
| # of recs in ABR | NA |
| Average Target Price | NA |
| Industry Rank by ABR | 110 out of 265 |
| Rank in Industry | NA |
